Patents by Inventor Christopher M. Beaudry

Christopher M. Beaudry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Analogues and derivatives of cephalotaxine and methods for making and using the compounds
    Patent number: 11708377
    Abstract: Disclosed herein are embodiments of a compound having a Formula I or a salt, solvate, N-oxide, prodrug, diastereomer or enantiomer thereof. Also disclosed are derivative compounds made from the compound of Formula I. Certain derivative compounds have a Formula V-2, or a salt, solvate, N-oxide, prodrug, diastereomer or enantiomer thereof. Also disclosed are method for making and using the disclosed compounds. Certain disclosed embodiments are useful for treating and/or preventing certain diseases and/or disorders, including proliferation diseases, such as leukemia.
    Type: Grant
    Filed: September 9, 2021
    Date of Patent: July 25, 2023
    Assignee: Oregon State University
    Inventors: Christopher M. Beaudry, Xuan Ju
  • REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS
    Publication number: 20230117370
    Abstract: Disclosed herein are embodiments of a method for making substituted compounds with specific and selectable regiochemistry. Also disclosed are compounds made by the method.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 20, 2023
    Applicant: Oregon State University
    Inventors: Christopher M. Beaudry, Xiaojie Zhang
  • ANALOGUES AND DERIVATIVES OF CEPHALOTAXINE AND METHODS FOR MAKING AND USING THE COMPOUNDS
    Publication number: 20220009944
    Abstract: Disclosed herein are embodiments of a compound having a Formula I or a salt, solvate, N-oxide, prodrug, diastereomer or enantiomer thereof. Also disclosed are derivative compounds made from the compound of Formula I. Certain derivative compounds have a Formula V-2, or a salt, solvate, N-oxide, prodrug, diastereomer or enantiomer thereof. Also disclosed are method for making and using the disclosed compounds. Certain disclosed embodiments are useful for treating and/or preventing certain diseases and/or disorders, including proliferation diseases, such as leukemia.
    Type: Application
    Filed: September 9, 2021
    Publication date: January 13, 2022
    Applicant: Oregon State University
    Inventors: Christopher M. Beaudry, Xuan Ju